Hester Biosciences Limited (BOM:524669)

Hester Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	20,004	10,741	10,667	11,818	12,934	23,099
Market Cap Growth	46.61%	0.70%	-9.74%	-8.63%	-44.00%	41.66%
Enterprise Value	20,893	12,929	13,063	14,503	15,490	24,167
Last Close Price	2351.55	1257.16	1244.14	1375.11	1498.02	2663.40

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	14.24	19.31	38.81	62.57	48.58	58.75
Forward PE	-	39.50	39.50	39.50	32.93	53.45
PS Ratio	5.79	3.22	3.41	3.80	4.65	9.37
PB Ratio	4.21	2.92	3.27	3.90	4.48	8.64
P/TBV Ratio	4.38	3.06	3.47	4.11	4.67	8.96
P/FCF Ratio	24.40	23.19	24.29	49.69	-	-
P/OCF Ratio	20.91	16.75	16.54	24.53	54.82	265.14
PEG Ratio	-	3.05	3.05	3.05	3.05	3.11

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	6.05	3.87	4.18	4.66	5.57	9.80
EV/EBITDA Ratio	20.72	15.83	23.22	24.17	24.81	33.90
EV/EBIT Ratio	25.21	18.66	28.63	33.63	36.86	43.91
EV/FCF Ratio	25.48	27.92	29.74	60.97	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.23	0.53	0.65	0.85	0.95	0.85
Debt / EBITDA Ratio	1.16	2.21	3.43	4.28	4.38	3.19
Debt / FCF Ratio	1.32	4.21	4.86	10.84	-	-
Net Debt / Equity Ratio	0.17	0.51	0.63	0.80	0.90	0.76
Net Debt / EBITDA Ratio	0.87	2.31	3.66	4.04	4.16	2.85
Net Debt / FCF Ratio	0.99	4.07	4.69	10.19	-4.79	-2.33
Asset Turnover	0.51	0.50	0.48	0.47	0.45	0.51
Inventory Turnover	1.17	1.23	1.27	1.24	1.03	0.99
Quick Ratio	1.10	0.72	0.70	0.95	0.68	0.85
Current Ratio	2.24	1.37	1.56	2.04	1.53	2.01
Return on Equity (ROE)	34.66%	16.55%	9.16%	7.16%	10.09%	15.69%
Return on Assets (ROA)	6.97%	6.51%	4.33%	4.05%	4.26%	7.07%
Return on Invested Capital (ROIC)	11.70%	9.65%	6.17%	5.23%	5.76%	10.22%
Return on Capital Employed (ROCE)	13.00%	13.20%	8.60%	7.70%	8.10%	11.80%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 5, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	7.02%	5.18%	2.58%	1.60%	2.06%	1.70%
FCF Yield	4.10%	4.31%	4.12%	2.01%	-4.19%	-3.77%
Dividend Yield	0.47%	0.87%	0.56%	0.43%	0.53%	0.37%
Payout Ratio	6.63%	10.83%	18.80%	36.28%	31.95%	21.63%
Total Shareholder Return	2.30%	0.87%	0.56%	0.43%	0.53%	0.37%

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error